Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Palisade Bio (PALI) Operating Margin (2016 - 2025)

Historic Operating Margin for Palisade Bio (PALI) over the last 14 years, with Q3 2025 value amounting to 58440.0%.

  • Palisade Bio's Operating Margin changed N/A to 58440.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 143212.5%, marking a year-over-year change of. This contributed to the annual value of 5228.0% for FY2023, which is N/A changed from last year.
  • As of Q3 2025, Palisade Bio's Operating Margin stood at 58440.0%.
  • Palisade Bio's Operating Margin's 5-year high stood at 231000.0% during Q1 2025, with a 5-year trough of 1011.6% in Q1 2023.
  • In the last 3 years, Palisade Bio's Operating Margin had a median value of 11600.0% in 2021 and averaged 63901.3%.
  • The largest annual percentage gain for Palisade Bio's Operating Margin in the last 5 years was 842400000bps (2021), contrasted with its biggest fall of 331783900bps (2021).
  • Palisade Bio's Operating Margin (Quarter) stood at 11600.0% in 2021, then plummeted by -109bps to 1011.6% in 2023, then surged by 5877bps to 58440.0% in 2025.
  • Its Operating Margin was 58440.0% in Q3 2025, compared to 142150.0% in Q2 2025 and 231000.0% in Q1 2025.